[ Price : $8.95]
FDA accepts for review Replimune's BLA resubmission that is seeking accelerated approval of RP1 (vusolimogene oderparepvec) in com...[ Price : $8.95]
FDA issues Sobi a Complete Response Letter on its BLA that is seeking approval of NASP (nanoencapsulated sirolimus plus pegadricas...[ Price : $8.95]
The European Commission opens a formal antitrust investigation into whether Sanofi abused its dominant market position by allegedl...[ Price : $8.95]
A new analysis of FDA inspection data suggests pharmaceutical manufacturing facilities in the U.S. received a higher proportion of...[ Price : $8.95]
FDA informs Capricor Therapeutics that it has scheduled an advisory committee meeting to review the company's BLA resubmission for...[ Price : $8.95]
FDA cites Dr. Reddy's Laboratories in a seven-observation Form 483 following a recent pre-license inspection of its biologics manu...[ Price : $8.95]
FDA issues Lantheus a Complete Response Letter for its NDA seeking approval for LNTH-2501 (gallium-68 edotreotide), a positron emi...[ Price : $8.95]
Three candidates emerge as finalists to become the next FDA commissioner, according to an Axios report citing sources familiar wit...